122 related articles for article (PubMed ID: 20598727)
1. Characterization of varicella-zoster virus-encoded ORF0 gene--comparison of parental and vaccine strains.
Koshizuka T; Ota M; Yamanishi K; Mori Y
Virology; 2010 Sep; 405(2):280-8. PubMed ID: 20598727
[TBL] [Abstract][Full Text] [Related]
2. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
[TBL] [Abstract][Full Text] [Related]
3. The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation.
Peters GA; Tyler SD; Carpenter JE; Jackson W; Mori Y; Arvin AM; Grose C
J Virol; 2012 Oct; 86(19):10695-703. PubMed ID: 22837206
[TBL] [Abstract][Full Text] [Related]
4. Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus.
Yoshii H; Somboonthum P; Takahashi M; Yamanishi K; Mori Y
Vaccine; 2007 Jun; 25(27):5006-12. PubMed ID: 17540483
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Whole-Genome Sequence of an Oka Varicella Vaccine from China with Other Oka Vaccine Strains Reveals Sites Putatively Critical for Vaccine Efficacy.
Wu Q; Rivailler P; Xu S; Xu W
J Virol; 2019 May; 93(9):. PubMed ID: 30728261
[TBL] [Abstract][Full Text] [Related]
6. A Variant Allele in Varicella-Zoster Virus Glycoprotein B Selected during Production of the Varicella Vaccine Contributes to Its Attenuation.
Sadaoka T; Depledge DP; Rajbhandari L; Breuer J; Venkatesan A; Cohen JI
mBio; 2022 Aug; 13(4):e0186422. PubMed ID: 35916400
[TBL] [Abstract][Full Text] [Related]
7. Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster.
Quinlivan ML; Jensen NJ; Radford KW; Schmid DS
J Clin Microbiol; 2012 May; 50(5):1533-8. PubMed ID: 22378912
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of the Oka vaccine strain of varicella-zoster virus.
Yamanishi K
J Infect Dis; 2008 Mar; 197 Suppl 2():S45-8. PubMed ID: 18419407
[TBL] [Abstract][Full Text] [Related]
9. Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo.
Che X; Zerboni L; Sommer MH; Arvin AM
J Virol; 2006 Apr; 80(7):3238-48. PubMed ID: 16537591
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system.
Zhang Z; Rowe J; Wang W; Sommer M; Arvin A; Moffat J; Zhu H
J Virol; 2007 Sep; 81(17):9024-33. PubMed ID: 17581997
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo.
Sato B; Ito H; Hinchliffe S; Sommer MH; Zerboni L; Arvin AM
J Virol; 2003 May; 77(10):5607-20. PubMed ID: 12719553
[TBL] [Abstract][Full Text] [Related]
12. Varicella-Zoster virus proteins encoded by open reading frames 14 and 67 are both dispensable for the establishment of latency in a rat model.
Grinfeld E; Sadzot-Delvaux C; Kennedy PG
Virology; 2004 May; 323(1):85-90. PubMed ID: 15165821
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.
Quinlivan M; Gershon AA; Steinberg SP; Breuer J
J Med Virol; 2005 Jan; 75(1):174-80. PubMed ID: 15543576
[TBL] [Abstract][Full Text] [Related]
14. Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine.
Somboonthum P; Yoshii H; Okamoto S; Koike M; Gomi Y; Uchiyama Y; Takahashi M; Yamanishi K; Mori Y
Vaccine; 2007 Dec; 25(52):8741-55. PubMed ID: 18053621
[TBL] [Abstract][Full Text] [Related]
15. Vaccine Oka variants and sequence variability in vaccine-related skin lesions.
Breuer J; Schmid DS
J Infect Dis; 2008 Mar; 197 Suppl 2():S54-7. PubMed ID: 18419409
[TBL] [Abstract][Full Text] [Related]
16. DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.
Gomi Y; Ozaki T; Nishimura N; Narita A; Suzuki M; Ahn J; Watanabe N; Koyama N; Ushida H; Yasuda N; Nakane K; Funahashi K; Fuke I; Takamizawa A; Ishikawa T; Yamanishi K; Takahashi M
Vaccine; 2008 Oct; 26(44):5627-32. PubMed ID: 18706951
[TBL] [Abstract][Full Text] [Related]
17. A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes.
Connors M; Crowe JE; Firestone CY; Murphy BR; Collins PL
Virology; 1995 Apr; 208(2):478-84. PubMed ID: 7747420
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
[TBL] [Abstract][Full Text] [Related]
19. Use of a rodent model to show that varicella-zoster virus ORF61 is dispensable for establishment of latency.
Sato H; Pesnicak L; Cohen JI
J Med Virol; 2003; 70 Suppl 1():S79-81. PubMed ID: 12627493
[TBL] [Abstract][Full Text] [Related]
20. Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVax.
Kim JI; Jung GS; Kim YY; Ji GY; Kim HS; Wang WD; Park HS; Park SY; Kim GH; Kwon SN; Lee KM; Ahn JH; Yoon Y; Lee CH
Virol J; 2011 Dec; 8():547. PubMed ID: 22176950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
